Moderna PharmD
Fellowship Program
Moderna, in collaboration with Howard University,
is pleased to offer 2 PharmD fellowships in Medical
Affairs to expose qualified Doctor of Pharmacy
graduates to the biopharmaceutical industry, and
to enhance the unique insights Pharmacists can
contribute. The fellowship is two years in duration
and will be based out of Moderna’s headquarters in
Cambridge, Massachusetts.
Francesca Ceddia
Chief Medical Affairs Officer
TABLE OF CONTENTS
3 Company Background
4 Moderna’s Pipeline
6 Moderna’s Values
7 Fellowship Offerings 2025
8 Medical Affairs PharmD Fellowships
10 Application & Recruitment Process
2
Company Background
Moderna is a leader in the creation of the field of Having demonstrated clinical benefit in multiple
messenger RNA (mRNA) medicine. By working infectious disease areas and skin cancer, as
at the intersection of science, technology well as potential clinical benefit for several rare
and health for more than a decade, we have genetic diseases, we continue to advance a
developed medicines at unprecedented speed broad and diverse pipeline and are focused on
and efficiency, including one of the earliest and execution to deliver for patients. Our pipeline
most effective COVID-19 vaccines. includes 47 therapeutic and vaccine programs,
nine of which are in late-stage development.
Our mRNA platform has enabled the
development of therapeutics and vaccines for To learn more, visit modernatx.com.
infectious diseases, immuno-oncology, rare
diseases and autoimmune diseases. With a
unique culture and a global team driven by the
Moderna values and mindsets to responsibly
change the future of human health, we strive to
deliver the greatest possible impact to people
through mRNA medicines.
Our first commercial product, Spikevax (our
COVID-19 vaccine), has helped hundreds of
millions of people worldwide combat COVID-19.
SARS-CoV-2, the virus that causes COVID-19,
continues to evolve and in 2023, the COVID-19 Moderna’s mission is to
vaccine market transitioned to an endemic, deliver the greatest possible
seasonal commercial market. Our second
commercial product, mRESVIA, an RSV vaccine, impact to people through
was approved by the FDA in May 2024. mRNA medicines.
3
Moderna’s Pipeline
Respiratory virus vaccines
Preclinical Ph 1 Ph 2 Ph 3 Commercial
COVID-19 vaccine Spikevax®
COVID-19 vaccine Next gen mRNA-1283
mRNA-1010
mRNA-1020
Flu vaccines mRNA-1030
mRNA-1011
Adults mRNA-1012
RSV vaccine Older adults mRESVIA®
Flu + COVID vaccine mRNA-1083
Flu + COVID + RSV vaccine mRNA-1230
Flu + RSV vaccine mRNA-1045
Pandemic Flu vaccine mRNA-1018
RSV + hMPV vaccine mRNA-1365
COVID-19 vaccine Adolescents mRNA-1273
Adolescents &
COVID-19 vaccine Pediatrics mRNA-1273
Pediatrics
RSV vaccine Pediatrics mRNA-1345
Latent + other virus vaccines
Preclinical Ph 1 Ph 2 Ph 3 Commercial
CMV vaccine mRNA-1647
EBV vaccine mRNA-1189
to prevent infectious mononucleosis
EBV vaccine mRNA-1195
to prevent long term EBV sequelae
Latent
vaccines HSV vaccine mRNA-1608
VZV vaccine mRNA-1468
mRNA-1644
HIV vaccines
mRNA-1547
mRNA-1403
Enteric Norovirus vaccine
vaccines mRNA-1405
Bacterial mRNA-1975
Lyme disease vaccines
vaccines mRNA-1982
Zika vaccine mRNA-1893
Public health Nipah vaccine mRNA-1215
vaccines
Mpox vaccine mRNA-1769
Updated September 2024
4
Oncology therapeutics
Ph 1 Ph 2 Ph 3 Commercial
Adjuvant melanoma mRNA-4157
Adjuvant non-small cell lung cancer
mRNA-4157
(NSCLC)
Individualized
neoantigen Cutaneous squamous cell carcinoma
mRNA-4157
(cSCC)
therapy
Renal cell carcinoma (RCC) mRNA-4157
Bladder cancer mRNA-4157
Cancer antigen Checkpoint antigen specific therapy mRNA-4359
specific therapy
Rare disease therapeutics
Preclinical Ph 1 Ph 2 Ph 3 Commercial
Propionic acidemia (PA) mRNA-3927
Methylmalonic acidemia (MMA) mRNA-3705
Rare disease Glycogen Storage Disease Type 1a (GSD1a) mRNA-3745
intercellular
Ornithine transcarbamylase deficiency
therapeutics (OTC)
mRNA-3139
Phenylketonuria (PKU) mRNA-3210
Crigler-Najjar
mRNA-3351
Syndrome Type 1 (CN-1)
Inhaled mRNA-3692 /
pulmonary Cystic fibrosis (CF)*
VX-522
therapeutics
Updated September 2024
5
Moderna’s Values
Our values are built on a foundation of quality, integrity, and respect.
Bold Collaborative Curious Relentless
Deliver on the promise Accomplish goals by Seek to challenge Stay undaunted by
of mRNA technology to working together and and improve upon challenges and build
transform the lives of respecting others’ the status quo. quickly on successes.
patients. viewpoints. Be innovative. Be tenacious in pursuit of
Be a visionary. Be a part of one team. our mission for patients.
Moderna’s Mindsets
We act with urgency We pursue options in parallel We accept risk We obsess over learning
Action today compounds the to make the best choice later. as the only path to We don’t have to be the smartest—
lives saved tomorrow. impact. we have to learn the fastest.
We pivot fearlessly We question convention We push past possible We behave like owners
in the face of new data. because proven models don’t because greatness lives The solutions we’re building go
always fuel the future. outside of comfort zones. beyond any job description.
We act with dynamic range We remove viscosity We prioritize the platform We digitize everywhere possible
driving strategy and execution at the to encourage collective over any single product. using the power of digital
same time and at every step. action. information to maximize our impact
on patients.
6
Fellowship Offerings 2025
Medical Affairs PharmD Fellowships
2 Positions
7
Medical Affairs PharmD Fellowships
2 Positions
The Global Medical Affairs (GMA) team partners with healthcare professionals to
generate and share knowledge to advance practice and deliver on the promise
of therapies and vaccines derived from an mRNA platform. We play an active
role throughout the product lifecycle to ensure healthcare professionals, patients,
and payers have the necessary information to evaluate transformative therapies,
while building a sustainable and resilient function within Moderna. The fellow will
join the Global Medical Affairs team in Cambridge, Massachusetts.
The Global Medical Affairs team at Moderna will provide PharmD graduates
the opportunity to gain rapid experience in the pharmaceutical industry within
Medical Affairs while working on diverse projects to deepen their understanding
of product development and commercialization.
The fellow will focus on Medical Affairs strategy including scientific
communications and medical product strategy. The fellow may take part in
projects covering 2-3 medical affairs specialties, including:
• Medical Product Strategy in various therapeutic areas including vaccines,
oncology, and rare disease
• Scientific Communications
• Publications
• Medical Information
• Medical Affairs Operations
• Real World Evidence Generation
Projects will be assigned based on the fellow’s areas of interest and available
opportunities to build the fellow’s competencies as a medical affairs professional.
Additionally, the fellow may have the option to take part in a 1-3 month rotation in
another department outside of Global Medical Affairs at Moderna.
Ibtihal Raja
Regulatory Intelligence and Policy Manager
Global Regulatory Science
Global Regulatory Science Postdoctoral Fellow -
(September 2023- September 2024)
8
MEDICAL AFFAIRS PHARMD FELLOWSHIP CORE TEAM
Monica Fay
VP, Global Medical Affairs - Rare Disease & Therapeutics
Medical Affairs
Rachel Kennedy
Sr. Director, Medical Affairs - Scientific Communications
Medical Affairs
Anuj Walia
Sr. Director, Medical Publications
Medical Affairs
Jane Carroll
VP, Global Medical Operations
Medical Affairs
Bishoy Rizkalla
VP, Global Medical Affairs - Infectious Diseases
Medical Affairs
Alex Avila
VP, Global Medical Affairs, Oncology
Medical Affairs
Andre Araujo
Executive Director, Medical RWE
Medical Affairs
Nima Adl
Senior Manager, Medical Affairs HCP Engagement Lead
Medical Affairs
9
Application & Recruitment Process
Application Requirements
ELIGIBILITY APPLICATION REVIEW AND INTERVIEW TIMELINE
To be eligible for a Pharmaceutical Industry Fellowship Following a review of submitted applications,
at HUCOP, candidates should have graduated with preliminary interviews will begin in December 2024
PharmD or PhD, in Pharmaceutical Sciences or related during ASHP. Additional interviews, including final
discipline, or will be by the start of the Fellowship. rounds will take place in early 2025.
Candidates must hold a degree as of July 1st or the
Fellowship term. Candidates will be notified if selected for an interview.
The process is rigorous and competitive; therefore
(https://pharmacy.howard.edu/fellowship-program/ candidates should submit their applications well in
eligibility-requirements) advance of posted deadlines as priority will be given
to those who apply early.
APPLICATION PROCEDURE
2025 entry application opens on ASHP MIDYEAR & ONSITE INTERVIEWS
September 17, 2024 The fellowship program will be conducting in-person
interviews at the ASHP Midyear Clinical Meeting in
2025 entry application must be completed by New Orleans, LA. Applicants are strongly encouraged
November 23, 2024 to attend, but it is not required. Candidates attending
in-person will not be able to interview without
(https://pharmacy.howard.edu/fellowship-program/ registering for both ASHP and PPS. Please refer to
about-fellowship-program) the ASHP & PPS website for registration details.
Top candidates may be invited for interviews at the
APPLICATION REQUIREMENTS sponsoring company’s location.
1. Curriculum Vitae
2. Letter of Intent
3. 3 Letters of Recommendation
4. Transcript of Pharm.D./PhD coursework
Contact : HUCOP Fellowship Program
(pharmacy.fellowship@howard.edu)
10
As a fellow in Moderna’s Regulatory Policy and Intelligence
function, I’ve had an incredible opportunity to immerse myself
in the forefront of biopharmaceutical innovation. Having access
to and learning from industry leaders in such a cutting-edge
technology company has been truly transformative. This
fellowship has not only exposed me to new and exciting
landscapes in pharma, but it also emphasizes a patient-first
approach in everything we do. I’ve been fortunate to work in
an environment that fosters collaboration and mentorship,
where everyone is eager to teach and guide. I have been given
opportunities to lead relevant and important projects as a fellow,
building my skillset as an industry professional and preparing
me to serve as a subject matter expert. The flexibility to tailor
my fellowship experience to my interests has allowed me to
lead initiatives that resonate with my passion for solutions.
Alongside the professional growth this fellowship offers, it is
genuinely about contributing to a mission that impacts lives.
- Ibtihal Raja
